Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
GeoVax Labs (GOVX)
NASDAQ:GOVX
GeoVax Labs (GOVX) Stock Price & Analysis
308 Followers
GOVX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.38 - $11.54
Previous Close$1.45
Volume11.03K
Average Volume (3M)40.45K
Market Cap
$3.35M
Enterprise Value-$9.34M
Total Cash (Recent Filing)$12.69M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-0.1
Beta4.10
Next Earnings
Aug 13, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-14.28
Shares Outstanding2,172,272
10 Day Avg. Volume26,388
30 Day Avg. Volume40,447
Standard Deviation0.46
R-Squared0.12
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)0.33
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.60
Forecast
1Y Price Target
$6.00Price Target Upside322.54% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
GeoVax Labs News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
GOVX FAQ
What was GeoVax Labs’s price range in the past 12 months?
GeoVax Labs lowest stock price was $1.38 and its highest was $11.54 in the past 12 months.
What is GeoVax Labs’s market cap?
Currently, no data Available
When is GeoVax Labs’s upcoming earnings report date?
GeoVax Labs’s upcoming earnings report date is Aug 13, 2024 which is in 102 days.
How were GeoVax Labs’s earnings last quarter?
Currently, no data Available
Is GeoVax Labs overvalued?
According to Wall Street analysts GeoVax Labs’s price is currently Undervalued.
Does GeoVax Labs pay dividends?
GeoVax Labs does not currently pay dividends.
What is GeoVax Labs’s EPS estimate?
GeoVax Labs’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GeoVax Labs have?
GeoVax Labs has 2,308,309 shares outstanding.
What happened to GeoVax Labs’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of GeoVax Labs?
Currently, no hedge funds are holding shares in GOVX
---
GeoVax Labs Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$6.00 (322.54% Upside)
$6.00 (322.54% Upside)
Insider Transactions
Bought Shares
Worth $25.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-83.67%
12-Months-Change
Fundamentals
Return on Equity
-160.47%
Trailing 12-Months
Asset Growth
-70.39%
Trailing 12-Months
Company Description
GeoVax Labs
GeoVax Labs, Inc. is a clinical-stage biotechnology company, which engages in the development of human vaccines and immunotherapies against infectious diseases and cancer using its novel vaccine platform. It focuses on human immunodeficiency virus, zika virus, hemorrhagic fever viruses, and malaria. The company was founded by Harriet Latham Robinson and Donald G. Hildebrand on September 9, 2006 and is headquartered in Smyrna, GA.
---
GOVX Earnings Call
Q4 2024
0:00 / 0:00
---
GOVX Stock 12 Months Forecast
Average Price Target
$6.00
▲(322.54% Upside)
Technical Analysis
Best Analysts Covering GOVX
1 Year
1 Year Success Rate
0/7 ratings generated profit
1 Year Average Return
-71.60%
reiterated a buy rating 6 months ago
Copying Vernon Bernardino's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -71.60% per trade.
---